Showing 1 - 9 results of 9 for search 'Frederik Boetius Hertz', query time: 0.03s Refine Results
  1. 1
    In vitro Relative Fitness, in vivo Intestinal Colonization and Genomic Differences of Escherichia coli of ST131 Carrying blaCTX–M–15

    In vitro Relative Fitness, in vivo Intestinal Colonization and Genomic Differences of Escherichia coli of ST131 Carrying blaCTX–M–15 by Frederik Boëtius Hertz, Rasmus L. Marvig, Niels Frimodt-Møller, Karen Leth Nielsen

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Growth Rate of <i>Escherichia coli</i> During Human Urinary Tract Infection: Implications for Antibiotic Effect

    Growth Rate of <i>Escherichia coli</i> During Human Urinary Tract Infection: Implications for Antibiotic Effect by Maria Schei Haugan, Frederik Boëtius Hertz, Godefroid Charbon, Berivan Sahin, Anders Løbner-Olesen, Niels Frimodt-Møller

    Published 2019-07-01
    Get full text
    Article
  3. 3
    <i>Listeria Monocytogenes</i> Brain Abscesses in a Patient with Disseminated Non-Small Cellular Lung Cancer: MRI Findings

    <i>Listeria Monocytogenes</i> Brain Abscesses in a Patient with Disseminated Non-Small Cellular Lung Cancer: MRI Findings by Anders Lykkemark Simonsen, Nitesh Shekhrajka, Frederik Boëtius Hertz, Jannik Helweg-Larsen, Åse Bengård Andersen, Anne-Mette Lebech

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Effects of Antibiotics on the Intestinal Microbiota of Mice

    Effects of Antibiotics on the Intestinal Microbiota of Mice by Frederik Boetius Hertz, Andries E. Budding, Malieka van der Lugt-Degen, Paul H. Savelkoul, Anders Løbner-Olesen, Niels Frimodt-Møller

    Published 2020-04-01
    Get full text
    Article
  5. 5
    Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial

    Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial by Filip Jansåker, Sara Thønnings, Frederik Boëtius Hertz, Thomas Kallemose, Jan Værnet, Lars Bjerrum, Thomas Benfield, Niels Frimodt-Møller, Jenny Dahl Knudsen

    Published 2019-07-01
    Get full text
    Article
  6. 6
    Mutational change of CTX‐M‐15 to CTX‐M‐127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient

    Mutational change of CTX‐M‐15 to CTX‐M‐127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient by Karen Leth Nielsen, Katrine Hartung Hansen, Jesper Boye Nielsen, Jenny Dahl Knudsen, Kristian Schønning, Niels Frimodt‐Møller, Frederik Boëtius Hertz, Filip Jansåker

    Published 2019-12-01
    Get full text
    Article
  7. 7
    Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients

    Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients by Kristian Bagge, Pradeesh Sivapalan, Josefin Eklöf, Frederik Böetius Hertz, Christian Østergaard Andersen, Ejvind Frausing Hansen, Jens Otto Jarløv, Jens-Ulrik Stæhr Jensen

    Published 2021-01-01
    Get full text
    Article
  8. 8
    Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>

    Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> by Karoline Knudsen List, Mette Kolpen, Kasper Nørskov Kragh, Godefroid Charbon, Stine Radmer, Frank Hansen, Anders Løbner-Olesen, Niels Frimodt-Møller, Frederik Boetius Hertz

    Published 2022-09-01
    Get full text
    Article
  9. 9
    Microbiome Compositions and Resistome Levels after Antibiotic Treatment of Critically Ill Patients: An Observational Cohort Study

    Microbiome Compositions and Resistome Levels after Antibiotic Treatment of Critically Ill Patients: An Observational Cohort Study by Karen Leth Nielsen, Markus Harboe Olsen, Albert Pallejá, Søren Røddik Ebdrup, Nikolaj Sørensen, Oksana Lukjancenko, Rasmus L. Marvig, Kirsten Møller, Niels Frimodt-Møller, Frederik Boëtius Hertz

    Published 2021-12-01
    Get full text
    Article

Search Tools: